Literature DB >> 3096706

AE mice: an inbred mouse strain with interesting features for epilepsy research.

W Löscher, S J Czuczwar, G L Wolff.   

Abstract

Spontaneous clonic-tonic seizures were occasionally observed in inbred AE mice of both sexes. Determination of seizure thresholds in this strain showed that both female and male AE mice had electroconvulsive thresholds that were markedly lower than those of other strains of mice, whereas susceptibility to seizures induced by pentylenetetrazol was not increased. The antiepileptic drug phenobarbital was much less effective in blocking electroconvulsions in AE mice than in other strains. Similarly, valproic acid was less effective in protecting against pentylenetetrazol-induced seizures. These differences in anticonvulsant efficacy could be explained only partly by differences in pharmacokinetics, thus indicating a lower responsiveness of AE mice to antiepileptic drugs. Determination of the GABA-synthesizing enzyme glutamic decarboxylase in different brain regions showed no significant difference between AE mice and normal NMRI mice except for a lower GAD activity in corpus striatum of male AE mice. The data indicate that AE mice may be an interesting new genetic model of epilepsy.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3096706     DOI: 10.1111/j.1528-1157.1986.tb03592.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  2 in total

Review 1.  The relevance of inter- and intrastrain differences in mice and rats and their implications for models of seizures and epilepsy.

Authors:  Wolfgang Löscher; Russell J Ferland; Thomas N Ferraro
Journal:  Epilepsy Behav       Date:  2017-06-23       Impact factor: 2.937

2.  Traumatic brain injury during development reduces minimal clonic seizure thresholds at maturity.

Authors:  Kimberly D Statler; Seth Swank; Tracy Abildskov; Erin D Bigler; H Steve White
Journal:  Epilepsy Res       Date:  2008-05-19       Impact factor: 3.045

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.